September 12, 2016 / 12:57 PM / in a year

BRIEF-Eyegate says is eligible to get additional milestone payment from Valeant for EGP-437

Sept 12 (Reuters) - Eyegate Receives Additional Milestone Payment From Valeant Pharmaceuticals For Egp

* Granted valeant exclusive commercial and manufacturing rights to company's eyegate ii delivery system, EGP-437 combination product

* Company is eligible to receive milestone payments totaling up to $32.5 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below